Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
thiostrepton (RSO-021)
i
Other names:
RSO-021
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
RS Oncology
Drug class:
Protein synthesis inhibitor, PRX3 inhibitor
Related drugs:
‹
MT-5111 (4)
omacetaxine mepesuccinate (4)
moxetumomab pasudotox (2)
recombinant (2)
MT-0169 (1)
Imtox19/Imtox22 (0)
MT-3724 (0)
OXS-1550 (0)
SVC112 (0)
oportuzumab monatox (0)
minocycline (0)
MT-5111 (4)
omacetaxine mepesuccinate (4)
moxetumomab pasudotox (2)
recombinant (2)
MT-0169 (1)
Imtox19/Imtox22 (0)
MT-3724 (0)
OXS-1550 (0)
SVC112 (0)
oportuzumab monatox (0)
minocycline (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.